Taiwan FDA registration 189fa81f43f89be0b3ff6215d0f096d8

Longteng benzodiazepine (rape pill) in vitro reagent group

TW: 龍騰苯二氮泮(強姦藥丸)體外試劑組
Taiwan flagTaiwan·Risk Class 2·The first factory of Longteng Biotechnology Co., Ltd·Registered Sep 09, 2008 – Sep 09, 2018Cancelled
Registration details
Analysis ID
189fa81f43f89be0b3ff6215d0f096d8
Customs Code
DHY00500259905
Company information
Manufacturer Country
Taiwan, Province of China
Product details
Intended Use
Qualitative detection of benzodiazepines (rape pills) and their metabolites in human urine.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.3170 Benzodiazo salt test system
Import Information
Domestic
Dates and status
Registration Date
Sep 09, 2008
Expiry Date
Sep 09, 2018
Cancellation Date
Jun 27, 2022
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
About this record

Access comprehensive regulatory information for Longteng benzodiazepine (rape pill) in vitro reagent group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 189fa81f43f89be0b3ff6215d0f096d8 and manufactured by The first factory of Longteng Biotechnology Co., Ltd. The authorized representative in Taiwan is The first factory of Longteng Biotechnology Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices